Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
High list prices and limited insurance coverage of glucagon-like peptide-1 drugs, or GLP-1s, have strained affordability for consumers
doi: 10.3389/fnins.2025.1671955 Received 24 July 2025 Revised 10 December 2025 Accepted 16 December 2025 Published 13 January 2026 Volume 19 - 2025 Edited by Fangchen Gong, Shanghai Jiao Tong University, China Reviewed by Al-Shaimaa Faissal Ahmed, Minia University, Egypt John Sieh Dumbuya, Affiliated Hospital of Guangdong Medical University, China Updates Copyright 2026 Li, Wang, Ma, Peng, Wang, Wang, Li and Wang
The study also underscores the importance of advanced data preprocessing techniques in ensuring the reliability of ML models
[PMID: 38807009] PubMed record related to this compound for laboratory literature review
Wegovy contains semaglutide, which acts primarily on the GLP-1 receptor to influence appetite and blood-sugar regulation
US$ 29.38
US$ 20.33
US$ 26.13
US$ 20.39
US$ 25.95
US$ 22.27
US$ 27.84
US$ 21.58
